Creatine kinase S-type, mitochondrial

BE0000410ProteinHumansCKMT2

Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). It is acted on by 2 drugs in DrugBank.

Gene name
CKMT2
UniProtKB entry
P17540Swiss-Prot
Cellular location
Mitochondrion inner membrane
Residues / weight
419 residues · 47,504 Da
Also known as
2.7.3.2 · Basic-type mitochondrial creatine kinase · Mib-CK · S-MtCK · Sarcomeric mitochondrial creatine kinase

Resolves to

Protein
UniProtP17540UniProt nameKCRS_HUMAN
Gene
HGNCHGNC:1996NCBI Gene1160GenBank338237GeneCardsCKMT2
Pharmacology
KEGGhsa:1160
Structure
PDB4Z9M
Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
4GO termsFunction, process and component, as structured annotations
Sign in
2Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which approved drugs act on Creatine kinase S-type, mitochondrial, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In